echemi logo
Product
  • Product
  • Supplier
  • Inquiry
    Home > Active Ingredient News > Study of Nervous System > China's first "White Paper on the Survey of the Awareness and Outcome Rate of Alzheimer's Disease among Chinese People in the Preclinical Phase 2021" is released

    China's first "White Paper on the Survey of the Awareness and Outcome Rate of Alzheimer's Disease among Chinese People in the Preclinical Phase 2021" is released

    • Last Update: 2021-10-01
    • Source: Internet
    • Author: User
    Search more information of high quality chemicals, good prices and reliable suppliers, visit www.echemi.com
    Guided Reading On September 15, 2021, the "White Paper 2021 on the Survey of the Awareness and Visiting Rates of Alzheimer's Disease among Chinese in the Preclinical Period" (hereinafter referred to as the "White Paper") was publicly released to the whole society
    .

    This survey was initiated by Professor Han Ying, and 180 hospitals from the National Geriatrics Clinical Medicine Research Center (Xuanwu Hospital)-China AD Preclinical Alliance actively participated, revealing the public's awareness of Alzheimer's disease and the existing problems in China
    .

    The "White Paper" survey shows that the respondents' awareness of AD and AD pre-clinical subjective cognitive decline (SCD) is not low, but the potential reason for the low rate of active consultation may be the public's insufficient awareness and insufficient attention to them
    .

    Professor Han Ying said that he will promote the widespread dissemination of the "White Paper", increase public awareness and attention to early AD, and help early detection, early diagnosis, early treatment, and early benefit in the pre-clinical phase.
    This is in line with this year's theme: "Knowing the enemy Confidant, early diagnosis and early wisdom"
    .

    This is China's first online survey on the awareness and consultation rate of AD in the preclinical stage of SCD.
    More than 15,000 valid questionnaires have been collected, covering 30 provinces, autonomous regions and municipalities directly under the Central Government
    .

    The "White Paper" conducts surveys from dimensions such as age, gender, occupation, economic level, education level, etc.
    , to understand patients' awareness of early AD and clinic visits, as well as the reasons behind the analysis
    .

    Figure 1 The questionnaire covers 30 provinces, autonomous regions, and municipalities across the country.
    Alzheimer's disease popularization is imminent.
    As the aging process continues to accelerate, the incidence of elderly diseases is also getting higher and higher, coupled with insufficient cognition, the incidence of AD It also shows a trend of increasing year by year.
    Once diagnosed, it is basically the middle and late stages.
    It is in the last two stages of the entire course of AD, which is equivalent to the terminal stage of cancer.
    It seriously affects the quality of life of patients and brings heavy mental and financial burdens to their relatives..

    According to the "World Alzheimer's Disease Report 2018", every 3 seconds, a new patient with dementia will be added worldwide, of which about 60-70% suffer from AD, which is the fifth leading cause of death in the world
    .

    In China, there are currently about 10 million people with AD dementia.
    It is estimated that by 2050, there will be more than 40 million people with AD dementia in China
    .

    "Early detection, early diagnosis, and early treatment in the pre-clinical stage are the only way to prevent and control AD
    .

    However, in daily life, people tend to be too contemptuous of such diseases, and always feel that they are not so serious or have no time to go to the doctor and cause delays
    .

    Therefore, It is particularly important to conduct popular science education for the general public and to improve their awareness and attention to early AD
    .

    "Professor Han Ying believes that this is the greatest significance of the release of this "White Paper"
    .

    September 21 is "World AD Day", and this year's theme is "Knowing the enemy and confidant, early diagnosis and early wisdom"
    .

    Obviously, the launch of the "White Paper" before this special day fits the theme very well and conveys a special meaning
    .

    Professor Han said that the joint investigation and analysis with 180 hospitals of the China AD Preclinical Alliance is aimed at strengthening the communication and learning of alliance members, and playing a positive role in the advancement of the "gateway" of AD prevention and treatment in China
    .

    Interpretation of Alzheimer's disease, authoritative guidance "Three Mornings" It is understood that the age of the questionnaire is concentrated in the middle-aged and young people, of which women account for a higher proportion of 63%
    .

    Figure 2 The number of people aged 21-30 is the largest, with the highest proportion of women.
    The respondents are mainly engaged in the medical and Internet industries, with a university degree or above accounting for the majority
    .

    Figure 3 Occupation distribution is mainly in the medical and Internet industries.
    It is understood that most married people participated in the survey, and the monthly disposable income is concentrated in 2000-5000 yuan/month and 5000-10000 yuan/month
    .

    Figure 4 Monthly Disposable Income Survey According to the "White Paper" survey, economic level, education level, etc.
    have no significant impact on the awareness rate of AD preclinical SCD
    .

    The unity of knowledge and action is very important
    .

    "Professor Han Ying said that it can be seen from the report that, in fact, the awareness rate of the concept of SCD in the preclinical stage of AD in China is not low, close to 80%, but the consultation rate is only 17%
    .

    It can be found from the survey that people often Various reasons will underestimate the disease.
    The common reasons are in descending order of proportion as follows: Work and life are under pressure recently, and it will be fine after a while; some people think that the hospital registration is too troublesome; or the work is too busy at ordinary times.
    Time; some people think that even if the early diagnosis is clear, there is no specific drug treatment; or that the symptoms are very light now, there should be no major problems; some people even think that people will get dementia when they grow old, and there is no need to see a doctor.
    .
    .
    Figure 5 Surveys on the reasons for the low rate of active consultations and other survey results reveal that the underlying reason for the low rate of active consultations is the lack of public awareness and insufficient attention to it
    .

    Professor Han Ying said that he will promote the widespread dissemination of the "White Paper" and increase public awareness of early AD The cognition and attention of the company guide everyone in early detection, early diagnosis, and early treatment in the pre-clinical stage.
    The theme of this year is proposed: Knowing the enemy and confidant, early diagnosis and early wisdom! Empowering health every day!
    This article is an English version of an article which is originally in the Chinese language on echemi.com and is provided for information purposes only. This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed description of the concern or complaint, to service@echemi.com. A staff member will contact you within 5 working days. Once verified, infringing content will be removed immediately.

    Contact Us

    The source of this page with content of products and services is from Internet, which doesn't represent ECHEMI's opinion. If you have any queries, please write to service@echemi.com. It will be replied within 5 days.

    Moreover, if you find any instances of plagiarism from the page, please send email to service@echemi.com with relevant evidence.